Envestnet Asset Management’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,596
Closed -$409K 3955
2022
Q3
$409K Sell
14,596
-18,780
-56% -$582K ﹤0.01% 3144
2022
Q2
$1.01M Buy
+33,376
New +$1.15M ﹤0.01% 2584
2021
Q2
Sell
-12,744
Closed -$422K 3638
2021
Q1
$422K Buy
+12,744
New +$438K ﹤0.01% 2943
2020
Q4
Sell
-13,243
Closed -$313K 3277
2020
Q3
$313K Sell
13,243
-4,580
-26% -$108K ﹤0.01% 2715
2020
Q2
$395K Buy
17,823
+6,730
+61% +$139K ﹤0.01% 2537
2020
Q1
$203K Sell
11,093
-1,422
-11% -$28.7K ﹤0.01% 2720
2019
Q4
$262K Buy
+12,515
New +$248K ﹤0.01% 2796

Other funds holding BOUT

Envestnet Asset Management's BOUT Position: Q4 2022 in Review

Envestnet Asset Management sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2022, closing a stake of 14,596 shares — an estimated $409K sold.

Envestnet Asset Management first reported a position in BOUT in Q4 2019 and held it in 7 quarters. The position peaked at $1.01M in Q2 2022. 8 funds tracked by Wall St. Rank hold BOUT as of Q4 2022.

  • Envestnet Asset Management reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 14,596 CapForce IBD Breakout Opportunities ETF shares in Q4 2022, an estimated $409K.
  • Envestnet Asset Management first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2019 and held it in 7 quarters.
  • Envestnet Asset Management's CapForce IBD Breakout Opportunities ETF position peaked at $1.01M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2022.

Based on Envestnet Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.